Delivery Order SPE2DB22D3016-SPE2DB24FANF2

Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $3,419.00 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under a set-aside designation. This award is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a ceiling value of $1,052.00 and a performance period through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor and the award does not utilize any set-aside designations. This delivery order is placed under an indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML medication. The $3,626.36 award has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a $999,999,999.00 indefinite delivery contract awarded to Amerisourcebergen Drug Corp by DLA to deliver...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit company AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of March 1, 2024 and a potential value of $2,458.22. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order has a potential value of $16,788.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that regularly provides pharmaceuticals and medical supplies to support U.S. government agencies,...
The Defense Logistics Agency (DLA) awarded a $1,578.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this order, which is not set aside for any specific business type....
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $3,982.37 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and has previously received numerous federal contract awards from DLA...
The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,365.96, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FANF2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a performance period through February 27, 2024 and a potential value of $2,367.00. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order contract.

Generated 6/2/24, 12:14 AM